Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples
Overview
Authors
Affiliations
Offering self-sampling of cervico-vaginal material for high-risk human papillomavirus (hrHPV) testing is an effective method to increase the coverage in cervical screening programs. Molecular triage directly on hrHPV-positive self-samples for colposcopy referral opens the way to full molecular cervical screening. Here, we set out to identify a DNA methylation classifier for detection of cervical precancer (CIN3) and cancer, applicable to lavage and brush self-samples. We determined genome-wide DNA methylation profiles of 72 hrHPV-positive self-samples, using the Infinium Methylation 450K Array. The selected DNA methylation markers were evaluated by multiplex quantitative methylation-specific PCR (qMSP) in both hrHPV-positive lavage ( = 245) and brush ( = 246) self-samples from screening cohorts. Subsequently, logistic regression analysis was performed to build a DNA methylation classifier for CIN3 detection applicable to self-samples of both devices. For validation, an independent set of hrHPV-positive lavage ( = 199) and brush ( = 287) self-samples was analyzed. Genome-wide DNA methylation profiling revealed 12 DNA methylation markers for CIN3 detection. Multiplex qMSP analysis of these markers in large series of lavage and brush self-samples yielded a 3-gene methylation classifier ( and ). This classifier showed a very good clinical performance for CIN3 detection in both lavage (AUC = 0.88; sensitivity = 74%; specificity = 79%) and brush (AUC = 0.90; sensitivity = 88%; specificity = 81%) self-samples in the validation set. Importantly, all self-samples from women with cervical cancer scored DNA methylation-positive. By genome-wide DNA methylation profiling on self-samples, we identified a highly effective 3-gene methylation classifier for direct triage on hrHPV-positive self-samples, which is superior to currently available methods. .
Yang J, Chen S, Liu Y, Wang P, Zhao J, Yi J Clin Transl Oncol. 2025; .
PMID: 39969762 DOI: 10.1007/s12094-025-03864-7.
Dick S, Heideman D, Berkhof J, Steenbergen R, Bleeker M Tumour Virus Res. 2024; 19():200308.
PMID: 39694193 PMC: 11728911. DOI: 10.1016/j.tvr.2024.200308.
Verhoef L, Bleeker M, Polman N, Kroon K, Steenbergen R, Ebisch R Int J Cancer. 2024; 156(5):1065-1073.
PMID: 39686532 PMC: 11701402. DOI: 10.1002/ijc.35289.
Schaafsma M, van den Helder R, Mom C, Steenbergen R, Bleeker M, van Trommel N Int J Cancer. 2024; 156(3):659-667.
PMID: 39175103 PMC: 11621989. DOI: 10.1002/ijc.35143.
Emerging paradigms: unmasking the role of oxidative stress in HPV-induced carcinogenesis.
Letafati A, Taghiabadi Z, Zafarian N, Tajdini R, Mondeali M, Aboofazeli A Infect Agent Cancer. 2024; 19(1):30.
PMID: 38956668 PMC: 11218399. DOI: 10.1186/s13027-024-00581-8.